| 1 |
Chang X, Obianwuna UE, Wang J, Zhang H, Qi G, Qiu K, Wu S. Glycosylated proteins with abnormal glycosylation changes are potential biomarkers for early diagnosis of breast cancer. Int J Biol Macromol 2023;236:123855. [PMID: 36868337 DOI: 10.1016/j.ijbiomac.2023.123855] [Reference Citation Analysis]
|
| 2 |
Kovalenko VL, Komedchikova EN, Sogomonyan AS, Tereshina ED, Kolesnikova OA, Mirkasymov AB, Iureva AM, Zvyagin AV, Nikitin PI, Shipunova VO. Lectin-Modified Magnetic Nano-PLGA for Photodynamic Therapy In Vivo. Pharmaceutics 2022;15. [PMID: 36678721 DOI: 10.3390/pharmaceutics15010092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Bian C, Sun X, Huang J, Zhang W, Mu G, Wei K, Chen L, Xia Y, Wang J. A novel glycosyltransferase-related lncRNA signature correlates with lung adenocarcinoma prognosis. Front Oncol 2022;12:950783. [DOI: 10.3389/fonc.2022.950783] [Reference Citation Analysis]
|
| 4 |
Radziejewska I, Supruniuk K, Tomczyk M, Izdebska W, Borzym-kluczyk M, Bielawska A, Bielawski K, Galicka A. p-Coumaric acid, Kaempferol, Astragalin and Tiliroside Influence the Expression of Glycoforms in AGS Gastric Cancer Cells. IJMS 2022;23:8602. [DOI: 10.3390/ijms23158602] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 5 |
Han Q, Wang X, Ding X, Hao J, Li Q, Wang J, Yu H, Tang Z, Yang F, Cai G, Zhang D, Zhu H. Salivary Glycopatterns as Potential Non-Invasive Biomarkers for Diagnosing and Reflecting Severity and Prognosis of Diabetic Nephropathy. Front Endocrinol 2022;13:790586. [DOI: 10.3389/fendo.2022.790586] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Zhuang Y, Li L, Wu H, Fang T, Kanjoormana Aryan M. CircRNA ACVR2A Sponges miR-1290 to Modulate Cell Progression in Gastric Cancer. Journal of Oncology 2022;2022:1-13. [DOI: 10.1155/2022/9461054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Tvaroška I. Glycosyltransferases as targets for therapeutic intervention in cancer and inflammation: molecular modeling insights. Chem Pap . [DOI: 10.1007/s11696-021-02026-7] [Reference Citation Analysis]
|
| 8 |
Fontiñan-rubio J, Peinado JR, Lindberg, Rabanal-ruiz Y. Molecular Principles, Components, Technology, and Concepts: Proteins – Posttranslational Modifications: Key Players in Health and Disease. Reference Module in Life Sciences 2022. [DOI: 10.1016/b978-0-12-821618-7.00093-6] [Reference Citation Analysis]
|
| 9 |
Nita-lazar A. Posttranslational Modifications: Key Players in Health and Disease. Reference Module in Life Sciences 2022. [DOI: 10.1016/b978-0-12-821618-7.00067-5] [Reference Citation Analysis]
|
| 10 |
Gornowicz A, Szymanowski W, Bielawski K, Kałuża Z, Michalak O, Bielawska A. Mucin 1 as a Molecular Target of a Novel Diisoquinoline Derivative Combined with Anti-MUC1 Antibody in AGS Gastric Cancer Cells. Molecules 2021;26:6504. [PMID: 34770912 DOI: 10.3390/molecules26216504] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 11 |
Radziejewska I, Supruniuk K, Czarnomysy R, Buzun K, Bielawska A. Anti-Cancer Potential of Afzelin towards AGS Gastric Cancer Cells. Pharmaceuticals (Basel) 2021;14:973. [PMID: 34681197 DOI: 10.3390/ph14100973] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 12 |
Supruniuk K, Czarnomysy R, Muszyńska A, Radziejewska I. Combined Action of Anti-MUC1 Monoclonal Antibody and Pyrazole-Platinum(II) Complexes Reveals Higher Effectiveness towards Apoptotic Response in Comparison with Monotherapy in AGS Gastric Cancer Cells. Pharmaceutics 2021;13:968. [PMID: 34206951 DOI: 10.3390/pharmaceutics13070968] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 13 |
Fernandes Â, Dias AM, Silva MC, Gaifem J, Azevedo CM, Carballo I, Pinho SS. The Role of Glycans in Chronic Inflammatory Gastrointestinal and Liver Disorders and Cancer. Comprehensive Glycoscience 2021. [DOI: 10.1016/b978-0-12-819475-1.00036-5] [Reference Citation Analysis]
|
| 14 |
El Rami FE, Barsoumian HB, Khneizer GW. Hereditary diffuse gastric cancer therapeutic roadmap: current and novel approaches in a nutshell. Ther Adv Med Oncol 2020;12:1758835920967238. [PMID: 33193828 DOI: 10.1177/1758835920967238] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 15 |
Zhou W, Jiang R, Wang Y, Li Y, Sun Z, Zhao H. hsa_circ_001653 up-regulates NR6A1 expression and elicits gastric cancer progression by binding to microRNA-377. Exp Physiol 2020;105:2141-53. [PMID: 33006200 DOI: 10.1113/EP088399] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 16 |
Sonkar C, Kashyap D, Varshney N, Baral B, Jha HC. Impact of Gastrointestinal Symptoms in COVID-19: a Molecular Approach. SN Compr Clin Med 2020;:1-12. [PMID: 33169110 DOI: 10.1007/s42399-020-00619-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 17 |
Zhao J, Qin R, Chen H, Yang Y, Qin W, Han J, Wang X, Ren S, Sun Y, Gu J. A nomogram based on glycomic biomarkers in serum and clinicopathological characteristics for evaluating the risk of peritoneal metastasis in gastric cancer. Clin Proteomics 2020;17:34. [PMID: 32968368 DOI: 10.1186/s12014-020-09297-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 18 |
Hu X, Tang F, Liu P, Zhong T, Yuan F, He Q, von Itzstein M, Li H, Weng L, Yu X. Structural and Functional Insight Into the Glycosylation Impact Upon the HGF/c-Met Signaling Pathway. Front Cell Dev Biol 2020;8:490. [PMID: 32626713 DOI: 10.3389/fcell.2020.00490] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 19 |
Corso G, Figueiredo J, De Angelis SP, Corso F, Girardi A, Pereira J, Seruca R, Bonanni B, Carneiro P, Pravettoni G, Guerini Rocco E, Veronesi P, Montagna G, Sacchini V, Gandini S. E-cadherin deregulation in breast cancer. J Cell Mol Med 2020;24:5930-6. [PMID: 32301282 DOI: 10.1111/jcmm.15140] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 20 |
Fernandes E, Sores J, Cotton S, Peixoto A, Ferreira D, Freitas R, Reis CA, Santos LL, Ferreira JA. Esophageal, gastric and colorectal cancers: Looking beyond classical serological biomarkers towards glycoproteomics-assisted precision oncology. Theranostics 2020;10:4903-28. [PMID: 32308758 DOI: 10.7150/thno.42480] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 21 |
Dusoswa SA, Verhoeff J, Abels E, Méndez-Huergo SP, Croci DO, Kuijper LH, de Miguel E, Wouters VMCJ, Best MG, Rodriguez E, Cornelissen LAM, van Vliet SJ, Wesseling P, Breakefield XO, Noske DP, Würdinger T, Broekman MLD, Rabinovich GA, van Kooyk Y, Garcia-Vallejo JJ. Glioblastomas exploit truncated O-linked glycans for local and distant immune modulation via the macrophage galactose-type lectin. Proc Natl Acad Sci U S A 2020;117:3693-703. [PMID: 32019882 DOI: 10.1073/pnas.1907921117] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 22 |
Kim S. Ricin B-like lectin orthologues from two mushrooms, Hericium erinaceus and Stereum hirsutum, enable recognition of highly fucosylated N-glycans. Int J Biol Macromol 2020;147:560-8. [PMID: 31931062 DOI: 10.1016/j.ijbiomac.2020.01.097] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 23 |
Verhelst X, Dias AM, Colombel JF, Vermeire S, Van Vlierberghe H, Callewaert N, Pinho SS. Protein Glycosylation as a Diagnostic and Prognostic Marker of Chronic Inflammatory Gastrointestinal and Liver Diseases. Gastroenterology 2020;158:95-110. [PMID: 31626754 DOI: 10.1053/j.gastro.2019.08.060] [Cited by in Crossref: 62] [Cited by in F6Publishing: 63] [Article Influence: 20.7] [Reference Citation Analysis]
|
| 24 |
Gomes C, Almeida A, Barreira A, Calheiros J, Pinto F, Abrantes R, Costa A, Polonia A, Campos D, Osório H, Sousa H, Pinto-de-Sousa J, Kolarich D, Reis CA. Carcinoembryonic antigen carrying SLeX as a new biomarker of more aggressive gastric carcinomas. Theranostics 2019;9:7431-46. [PMID: 31695778 DOI: 10.7150/thno.33858] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 25 |
Axford J, Alavi A, Cummings R, Lauc G, Opdenakker G, Reis C, Rudd P. Translational glycobiology: from bench to bedside. J R Soc Med 2019;112:424-7. [PMID: 31526214 DOI: 10.1177/0141076819865863] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 26 |
Ma M, Fu Y, Zhou X, Guan F, Wang Y, Li X. Functional roles of fucosylated and O-glycosylated cadherins during carcinogenesis and metastasis. Cell Signal 2019;63:109365. [PMID: 31352008 DOI: 10.1016/j.cellsig.2019.109365] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 27 |
Gebrehiwot AG, Melka DS, Kassaye YM, Gemechu T, Lako W, Hinou H, Nishimura SI. Exploring serum and immunoglobulin G N-glycome as diagnostic biomarkers for early detection of breast cancer in Ethiopian women. BMC Cancer 2019;19:588. [PMID: 31208374 DOI: 10.1186/s12885-019-5817-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 28 |
Zhang J, Zhong Y, Zhang P, Du H, Shu J, Liu X, Zhang H, Guo Y, Jia Z, Niu L, Yang F, Li Z. Identification of abnormal fucosylated-glycans recognized by LTL in saliva of HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Glycobiology 2019;29:242-59. [PMID: 30535277 DOI: 10.1093/glycob/cwy108] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 29 |
Shu J, Dang L, Zhang D, Shah P, Chen L, Zhang H, Sun S. Dynamic analysis of proteomic alterations in response to N-linked glycosylation inhibition in a drug-resistant ovarian carcinoma cell line. FEBS J 2019;286:1594-605. [PMID: 30884134 DOI: 10.1111/febs.14811] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 30 |
Freitas D, Campos D, Gomes J, Pinto F, Macedo JA, Matos R, Mereiter S, Pinto MT, Polónia A, Gartner F, Magalhães A, Reis CA. O-glycans truncation modulates gastric cancer cell signaling and transcription leading to a more aggressive phenotype. EBioMedicine 2019;40:349-62. [PMID: 30662000 DOI: 10.1016/j.ebiom.2019.01.017] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 9.8] [Reference Citation Analysis]
|
| 31 |
Ribaldone DG, Simondi D, Petrini E, Astegiano M, Durazzo M. Non-invasive biomarkers for gastric cancer diagnosis: ready for prime time? Minerva Biotecnol 2019;31. [DOI: 10.23736/s1120-4826.18.02463-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 32 |
Kim K, Choi KW, Lee WY. Clinicopathologic correlation with MUC expression in advanced gastric cancer. Korean J Clin Oncol 2018;14:89-94. [DOI: 10.14216/kjco.18016] [Reference Citation Analysis]
|
| 33 |
Jiang YY, Zheng SJ. Progress in research of sphingolipids in hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2018; 26(36): 2109-2114 [DOI: 10.11569/wcjd.v26.i36.2109] [Reference Citation Analysis]
|
| 34 |
Kim S. Hericium erinaceus isolectins recognize mucin-type O-glycans as tumor-associated carbohydrate antigens on the surface of K562 human leukemia cells. International Journal of Biological Macromolecules 2018;120:1093-102. [DOI: 10.1016/j.ijbiomac.2018.08.115] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 35 |
Liu M, Yu H, Zhang D, Han Q, Yang X, Liu X, Wang J, Zhang K, Yang F, Cai G, Chen X, Zhu H. Alteration of glycosylation in serum proteins: a new potential indicator to distinguish non-diabetic renal diseases from diabetic nephropathy. RSC Adv 2018;8:38872-82. [PMID: 35558281 DOI: 10.1039/c8ra06832a] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 36 |
Shu J, Yu H, Du H, Zhang J, Zhang K, Li X, Xie H, Li Z. Identification of N- and O-linked glycans recognized by AAL in saliva of patients with atrophic gastritis and gastric cancer. Cancer Biomark 2018;22:669-81. [PMID: 29865036 DOI: 10.3233/CBM-171087] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 37 |
Rodrigues JG, Balmaña M, Macedo JA, Poças J, Fernandes Â, de-Freitas-Junior JCM, Pinho SS, Gomes J, Magalhães A, Gomes C, Mereiter S, Reis CA. Glycosylation in cancer: Selected roles in tumour progression, immune modulation and metastasis. Cellular Immunology 2018;333:46-57. [DOI: 10.1016/j.cellimm.2018.03.007] [Cited by in Crossref: 99] [Cited by in F6Publishing: 103] [Article Influence: 19.8] [Reference Citation Analysis]
|
| 38 |
Jang M, Koh I, Lee JE, Lim JY, Cheong JH, Kim P. Increased extracellular matrix density disrupts E-cadherin/β-catenin complex in gastric cancer cells. Biomater Sci 2018;6:2704-13. [PMID: 30151505 DOI: 10.1039/c8bm00843d] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 7.2] [Reference Citation Analysis]
|
| 39 |
Radziejewska I, Supruniuk K, Nazaruk J, Karna E, Popławska B, Bielawska A, Galicka A. Rosmarinic acid influences collagen, MMPs, TIMPs, glycosylation and MUC1 in CRL-1739 gastric cancer cell line. Biomed Pharmacother 2018;107:397-407. [PMID: 30099344 DOI: 10.1016/j.biopha.2018.07.123] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 40 |
Barkeer S, Chugh S, Batra SK, Ponnusamy MP. Glycosylation of Cancer Stem Cells: Function in Stemness, Tumorigenesis, and Metastasis. Neoplasia 2018;20:813-25. [PMID: 30015157 DOI: 10.1016/j.neo.2018.06.001] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 41 |
Pena-Couso L, Perea J, Melo S, Mercadillo F, Figueiredo J, Sanches JM, Sánchez-Ruiz A, Robles L, Seruca R, Urioste M. Clinical and functional characterization of the CDH1 germline variant c.1679C>G in three unrelated families with hereditary diffuse gastric cancer. Eur J Hum Genet 2018;26:1348-53. [PMID: 29769627 DOI: 10.1038/s41431-018-0173-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 42 |
Morozov V, Borkowski J, Hanisch FG. The Double Face of Mucin-Type O-Glycans in Lectin-Mediated Infection and Immunity. Molecules 2018;23:E1151. [PMID: 29751628 DOI: 10.3390/molecules23051151] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 43 |
Shu J, Yu H, Li X, Zhang D, Liu X, Du H, Zhang J, Yang Z, Xie H, Li Z. Salivary glycopatterns as potential biomarkers for diagnosis of gastric cancer. Oncotarget 2017;8:35718-27. [PMID: 28415698 DOI: 10.18632/oncotarget.16082] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 44 |
Carvalho S, Oliveira T, Bartels MF, Miyoshi E, Pierce M, Taniguchi N, Carneiro F, Seruca R, Reis CA, Strahl S, Pinho SS. O-mannosylation and N-glycosylation: two coordinated mechanisms regulating the tumour suppressor functions of E-cadherin in cancer. Oncotarget 2016;7:65231-46. [PMID: 27533452 DOI: 10.18632/oncotarget.11245] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 45 |
Munkley J, Elliott DJ. Hallmarks of glycosylation in cancer. Oncotarget. 2016;7:35478-35489. [PMID: 27007155 DOI: 10.18632/oncotarget.8155] [Cited by in Crossref: 254] [Cited by in F6Publishing: 269] [Article Influence: 50.8] [Reference Citation Analysis]
|
| 46 |
Oliveira FMS, Mereiter S, Lönn P, Siart B, Shen Q, Heldin J, Raykova D, Karlsson NG, Polom K, Roviello F, Reis CA, Kamali-Moghaddam M. Detection of post-translational modifications using solid-phase proximity ligation assay. N Biotechnol 2018;45:51-9. [PMID: 29101055 DOI: 10.1016/j.nbt.2017.10.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 47 |
Duarte HO, Balmaña M, Mereiter S, Osório H, Gomes J, Reis CA. Gastric Cancer Cell Glycosylation as a Modulator of the ErbB2 Oncogenic Receptor. Int J Mol Sci 2017;18:E2262. [PMID: 29143776 DOI: 10.3390/ijms18112262] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 48 |
Parreira P, Soares BI, Freire CS, Silvestre AJ, Reis CA, Martins MCL, Duarte MF. Eucalyptus spp. outer bark extracts inhibit Helicobacter pylori growth: in vitro studies. Industrial Crops and Products 2017;105:207-14. [DOI: 10.1016/j.indcrop.2017.05.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 49 |
Saeui CT, Liu L, Urias E, Morrissette-McAlmon J, Bhattacharya R, Yarema KJ. Pharmacological, Physiochemical, and Drug-Relevant Biological Properties of Short Chain Fatty Acid Hexosamine Analogues Used in Metabolic Glycoengineering. Mol Pharm 2018;15:705-20. [PMID: 28853901 DOI: 10.1021/acs.molpharmaceut.7b00525] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 50 |
de-Freitas-Junior JCM, Andrade-da-Costa J, Silva MC, Pinho SS. Glycans as Regulatory Elements of the Insulin/IGF System: Impact in Cancer Progression. Int J Mol Sci 2017;18:E1921. [PMID: 28880250 DOI: 10.3390/ijms18091921] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 51 |
Guo Y, Shi J, Zhang J, Li H, Liu B, Guo H. Polypeptide N-acetylgalactosaminyltransferase-6 expression in gastric cancer. Onco Targets Ther 2017;10:3337-44. [PMID: 28744137 DOI: 10.2147/OTT.S138590] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 52 |
Qin R, Zhao J, Qin W, Zhang Z, Zhao R, Han J, Yang Y, Li L, Wang X, Ren S, Sun Y, Gu J. Discovery of Non-invasive Glycan Biomarkers for Detection and Surveillance of Gastric Cancer. J Cancer. 2017;8:1908-1916. [PMID: 28819389 DOI: 10.7150/jca.17900] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 53 |
Estrada-Martínez LE, Moreno-Celis U, Cervantes-Jiménez R, Ferriz-Martínez RA, Blanco-Labra A, García-Gasca T. Plant Lectins as Medical Tools against Digestive System Cancers. Int J Mol Sci 2017;18:E1403. [PMID: 28671623 DOI: 10.3390/ijms18071403] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 54 |
Gómez-Santos L, Alonso E, Díaz-Flores L, Madrid JF, Sáez FJ. Characterization by Lectin Histochemistry of Two Subpopulations of Parietal Cells in the Rat Gastric Glands. J Histochem Cytochem 2017;65:261-72. [PMID: 28438092 DOI: 10.1369/0022155417694871] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 55 |
Seabra CL, Nunes C, Gomez-lazaro M, Correia M, Machado JC, Gonçalves IC, Reis CA, Reis S, Martins MCL. Docosahexaenoic acid loaded lipid nanoparticles with bactericidal activity against Helicobacter pylori. International Journal of Pharmaceutics 2017;519:128-37. [DOI: 10.1016/j.ijpharm.2017.01.014] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 56 |
Ferreira JA, Magalhães A, Gomes J, Peixoto A, Gaiteiro C, Fernandes E, Santos LL, Reis CA. Protein glycosylation in gastric and colorectal cancers: Toward cancer detection and targeted therapeutics. Cancer Letters 2017;387:32-45. [DOI: 10.1016/j.canlet.2016.01.044] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 57 |
Li JH, Huang W, Lin P, Wu B, Fu ZG, Shen HM, Jing L, Liu ZY, Zhou Y, Meng Y, Xu BQ, Chen ZN, Jiang JL. N-linked glycosylation at Asn152 on CD147 affects protein folding and stability: promoting tumour metastasis in hepatocellular carcinoma. Sci Rep 2016;6:35210. [PMID: 27869218 DOI: 10.1038/srep35210] [Cited by in Crossref: 18] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 58 |
Carvalho S, Reis CA, Pinho SS. Cadherins Glycans in Cancer: Sweet Players in a Bitter Process. Trends Cancer 2016;2:519-31. [PMID: 28741480 DOI: 10.1016/j.trecan.2016.08.003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 59 |
Almeida A, Kolarich D. The promise of protein glycosylation for personalised medicine. Biochimica et Biophysica Acta (BBA) - General Subjects 2016;1860:1583-95. [DOI: 10.1016/j.bbagen.2016.03.012] [Cited by in Crossref: 61] [Cited by in F6Publishing: 65] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 60 |
Lauc G, Pezer M, Rudan I, Campbell H. Mechanisms of disease: The human N-glycome. Biochimica et Biophysica Acta (BBA) - General Subjects 2016;1860:1574-82. [DOI: 10.1016/j.bbagen.2015.10.016] [Cited by in Crossref: 125] [Cited by in F6Publishing: 130] [Article Influence: 17.9] [Reference Citation Analysis]
|
| 61 |
Duarte HO, Freitas D, Gomes C, Gomes J, Magalhães A, Reis CA. Mucin-Type O-Glycosylation in Gastric Carcinogenesis. Biomolecules 2016;6:E33. [PMID: 27409642 DOI: 10.3390/biom6030033] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 62 |
Barel M, Harduin-Lepers A, Portier L, Slomianny MC, Charbit A. Host glycosylation pathways and the unfolded protein response contribute to the infection by Francisella. Cell Microbiol 2016;18:1763-81. [PMID: 27185209 DOI: 10.1111/cmi.12614] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 63 |
Cornelissen LA, Van Vliet SJ. A Bitter Sweet Symphony: Immune Responses to Altered O-glycan Epitopes in Cancer. Biomolecules 2016;6:E26. [PMID: 27153100 DOI: 10.3390/biom6020026] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 64 |
Wang XT, Kong FB, Mai W, Li L, Pang LM. MUC1 Immunohistochemical Expression as a Prognostic Factor in Gastric Cancer: Meta-Analysis. Dis Markers 2016;2016:9421571. [PMID: 27190429 DOI: 10.1155/2016/9421571] [Cited by in Crossref: 19] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 65 |
Chia J, Goh G, Bard F. Short O-GalNAc glycans: regulation and role in tumor development and clinical perspectives. Biochim Biophys Acta 2016;1860:1623-39. [PMID: 26968459 DOI: 10.1016/j.bbagen.2016.03.008] [Cited by in Crossref: 71] [Cited by in F6Publishing: 76] [Article Influence: 10.1] [Reference Citation Analysis]
|
| 66 |
Lindberg I, Peinado J. Posttranslational Modifications: Key Players in Health and Disease. Encyclopedia of Cell Biology 2016. [DOI: 10.1016/b978-0-12-394447-4.10014-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 67 |
Pinho SS, Reis CA. Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer 2015;15:540-55. [PMID: 26289314 DOI: 10.1038/nrc3982] [Cited by in Crossref: 1664] [Cited by in F6Publishing: 1669] [Article Influence: 208.0] [Reference Citation Analysis]
|
| 68 |
Carvalho S, Catarino TA, Dias AM, Kato M, Almeida A, Hessling B, Figueiredo J, Gärtner F, Sanches JM, Ruppert T, Miyoshi E, Pierce M, Carneiro F, Kolarich D, Seruca R, Yamaguchi Y, Taniguchi N, Reis CA, Pinho SS. Preventing E-cadherin aberrant N-glycosylation at Asn-554 improves its critical function in gastric cancer. Oncogene 2016;35:1619-31. [PMID: 26189796 DOI: 10.1038/onc.2015.225] [Cited by in Crossref: 72] [Cited by in F6Publishing: 77] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 69 |
Magalhaes A, Marcos-Pinto R, Nairn AV, dela Rosa M, Ferreira RM, Junqueira-Neto S, Freitas D, Gomes J, Oliveira P, Santos MR. Helicobacter pylori chronic infection and mucosal inflammation switches the human gastric glycosylation pathways. Biochimica Et Biophys Acta-Molecular Basis Dis. 2015;1852:1928-1939. [PMID: 26144047 DOI: 10.1016/j.bbadis.2015.07.001] [Cited by in Crossref: 53] [Cited by in F6Publishing: 41] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 70 |
Marcos-pinto R. Genetic Variations and Gastric Cancer Risk. GE Portuguese Journal of Gastroenterology 2015;22:135-136. [DOI: 10.1016/j.jpge.2015.05.006] [Reference Citation Analysis]
|
| 71 |
Furukawa J, Tsuda M, Okada K, Kimura T, Piao J, Tanaka S, Shinohara Y. Comprehensive Glycomics of a Multistep Human Brain Tumor Model Reveals Specific Glycosylation Patterns Related to Malignancy. PLoS One 2015;10:e0128300. [PMID: 26132161 DOI: 10.1371/journal.pone.0128300] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 72 |
Campos D, Freitas D, Gomes J, Reis CA. Glycoengineered cell models for the characterization of cancer O-glycoproteome: an innovative strategy for biomarker discovery. Expert Review of Proteomics 2015;12:337-42. [DOI: 10.1586/14789450.2015.1059758] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 73 |
Campos D, Freitas D, Gomes J, Magalhães A, Steentoft C, Gomes C, Vester-Christensen MB, Ferreira JA, Afonso LP, Santos LL, Pinto de Sousa J, Mandel U, Clausen H, Vakhrushev SY, Reis CA. Probing the O-glycoproteome of gastric cancer cell lines for biomarker discovery. Mol Cell Proteomics 2015;14:1616-29. [PMID: 25813380 DOI: 10.1074/mcp.M114.046862] [Cited by in Crossref: 74] [Cited by in F6Publishing: 76] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 74 |
Nunes JB, Peixoto J, Soares P, Maximo V, Carvalho S, Pinho SS, Vieira AF, Paredes J, Rego AC, Ferreira IL, Gomez-lazaro M, Sobrinho-simoes M, Singh KK, Lima J. OXPHOS dysfunction regulates integrin- 1 modifications and enhances cell motility and migration. Human Molecular Genetics 2015;24:1977-90. [DOI: 10.1093/hmg/ddu612] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 75 |
Cheng Z, Liu F, Wang G, Li Y, Zhang H, Li F. miR-133 is a key negative regulator of CDC42-PAK pathway in gastric cancer. Cell Signal 2014;26:2667-73. [PMID: 25152372 DOI: 10.1016/j.cellsig.2014.08.012] [Cited by in Crossref: 37] [Cited by in F6Publishing: 43] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 76 |
Roy B, Chattopadhyay G, Mishra D, Das T, Chakraborty S, Maiti TK. On-chip lectin microarray for glycoprofiling of different gastritis types and gastric cancer. Biomicrofluidics. 2014;8:034107. [PMID: 24959308 DOI: 10.1063/1.4882778] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 77 |
Bassagañas S, Carvalho S, Dias AM, Pérez-Garay M, Ortiz MR, Figueras J, Reis CA, Pinho SS, Peracaula R. Pancreatic cancer cell glycosylation regulates cell adhesion and invasion through the modulation of α2β1 integrin and E-cadherin function. PLoS One 2014;9:e98595. [PMID: 24878505 DOI: 10.1371/journal.pone.0098595] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 78 |
Pinho SS, Reis CA. E-cadherin Glycosylation in Cancer. Glycoscience: Biology and Medicine 2014. [DOI: 10.1007/978-4-431-54836-2_54-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 79 |
Hara A, Imamura A, Ando H, Ishida H, Kiso M. A new chemical approach to human ABO histo-blood group type 2 antigens. Molecules 2013;19:414-37. [PMID: 24384923 DOI: 10.3390/molecules19010414] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
|
